Abstract
ejd.2011.1424 Auteur(s) : Valerie Failla1, Charlotte Castronovo1, Cecile Meex2, Arjen F Nikkels1 af.nikkels@chu.ulg.ac.be 1 Departments of Dermatology 2 Microbiology, CHU du Sart Tilman, 4000 Liege, Belgium The severity and duration of herpes zoster (HZ) commonly increase, and the incidence increases two-fold, in patients treated with TNF-alpha-antagonists [1]. That TNF-alpha plays a key role in cutaneous immunity against VZV is illustrated by the following case: A 32-year-old woman with Crohn's [...]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
